MA-17 Post-Unblinding and ITT Analyses

1
MA-17 Post-Unblinding and ITT Analyses Trial
Designs
Unblinding
Continued on Letrozole
Letrozole
Post-Unblinding Analysis
Tamoxifen
Journalof ClinicalOncologyGoss et. al
Placebo
Switched to Letrozole n 1579
5 years
Continued on Placebo n 804
Intent-to-Treat Analysis
Continued on Letrozole
Letrozole
Annals ofOncologyIngle et. al
Tamoxifen
Switched to Letrozole n 1579
Placebo
Continued on Placebo n 804
5 years
2003
2005
1998